{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1360021393795910144.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1016/j.jaut.2018.01.004"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0896841117307965?httpAccept=text/xml"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0896841117307965?httpAccept=text/plain"}}],"dc:title":[{"@value":"TGF-β signalling defect is linked to low CD39 expression on regulatory T cells and methotrexate resistance in rheumatoid arthritis"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1380021393795910148","@type":"Researcher","foaf:name":[{"@value":"Raphael S. Peres"}]},{"@id":"https://cir.nii.ac.jp/crid/1380021393795910144","@type":"Researcher","foaf:name":[{"@value":"Paula B. Donate"}]},{"@id":"https://cir.nii.ac.jp/crid/1380021393795910156","@type":"Researcher","foaf:name":[{"@value":"Jhimmy Talbot"}]},{"@id":"https://cir.nii.ac.jp/crid/1380021393795910151","@type":"Researcher","foaf:name":[{"@value":"Nerry T. Cecilio"}]},{"@id":"https://cir.nii.ac.jp/crid/1380021393795910155","@type":"Researcher","foaf:name":[{"@value":"Patricia R. Lobo"}]},{"@id":"https://cir.nii.ac.jp/crid/1380021393795910150","@type":"Researcher","foaf:name":[{"@value":"Caio C. Machado"}]},{"@id":"https://cir.nii.ac.jp/crid/1380021393795910145","@type":"Researcher","foaf:name":[{"@value":"Kalil W.A. Lima"}]},{"@id":"https://cir.nii.ac.jp/crid/1380021393795910146","@type":"Researcher","foaf:name":[{"@value":"Rene D. Oliveira"}]},{"@id":"https://cir.nii.ac.jp/crid/1380021393795910154","@type":"Researcher","foaf:name":[{"@value":"Vanessa Carregaro"}]},{"@id":"https://cir.nii.ac.jp/crid/1380021393795910157","@type":"Researcher","foaf:name":[{"@value":"Helder I. Nakaya"}]},{"@id":"https://cir.nii.ac.jp/crid/1380021393795910153","@type":"Researcher","foaf:name":[{"@value":"Thiago M. Cunha"}]},{"@id":"https://cir.nii.ac.jp/crid/1380021393795910152","@type":"Researcher","foaf:name":[{"@value":"José Carlos Alves-Filho"}]},{"@id":"https://cir.nii.ac.jp/crid/1380021393795910147","@type":"Researcher","foaf:name":[{"@value":"Foo Y. Liew"}]},{"@id":"https://cir.nii.ac.jp/crid/1380021393795910158","@type":"Researcher","foaf:name":[{"@value":"Paulo Louzada-Junior"}]},{"@id":"https://cir.nii.ac.jp/crid/1380021393795910149","@type":"Researcher","foaf:name":[{"@value":"Fernando Q. Cunha"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"08968411"}],"prism:publicationName":[{"@value":"Journal of Autoimmunity"}],"dc:publisher":[{"@value":"Elsevier BV"}],"prism:publicationDate":"2018-06","prism:volume":"90","prism:startingPage":"49","prism:endingPage":"58"},"reviewed":"false","dc:rights":["https://www.elsevier.com/tdm/userlicense/1.0/","https://www.elsevier.com/legal/tdmrep-license"],"url":[{"@id":"https://api.elsevier.com/content/article/PII:S0896841117307965?httpAccept=text/xml"},{"@id":"https://api.elsevier.com/content/article/PII:S0896841117307965?httpAccept=text/plain"}],"createdAt":"2018-02-13","modifiedAt":"2025-10-12","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360302865548787840","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"TAp63, a methotrexate target in CD4+ T cells, suppresses Foxp3 expression and exacerbates autoimmune arthritis"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1016/j.jaut.2018.01.004"},{"@type":"CROSSREF","@value":"10.1172/jci.insight.164778_references_DOI_VmZmCnZ3xPKs5tZQptDHTzjm100"}]}